Lynem-P Tablet

Paracetamol complements this action through central analgesic and antipyretic mechanisms, providing effective pain relief and fever reduction. The synergistic effect of these two agents allows for enhanced efficacy in alleviating moderate pain while minimizing gastrointestinal side effects commonly associated with non-selective NSAIDs. Lynem-P is typically administered orally, with dosage tailored according to the severity of symptoms and patient response.

Caution is advised in patients with hepatic or renal impairment, and it should be used under medical supervision to avoid potential adverse effects such as hepatotoxicity or hypersensitivity reactions. This combination is contraindicated in patients with known hypersensitivity to either component, active peptic ulcer, or severe liver dysfunction. Lynem-P Tablet offers a balanced therapeutic option for effective pain and inflammation management in clinical practice.